oncogene-induced senescence initial barrier lymphoma development
acute induction oncogenic ras provokes cellular senescence involving retinoblastoma rb pathway tumour suppressive potential senescence vivo remains elusive recently rb-mediated silencing growth-promoting genes heterochromatin formation associated methylation histone h3 lysine h3k9me identified critical feature cellular senescence may depend histone methyltransferase suv39h1 show e mu-n-ras transgenic mice harbouring targeted heterozygous lesions suv39h1 p53 locus comparison succumb invasive t-cell lymphomas lack expression suv39h1 p53 respectively contrast n-ras-transgenic wild-type control animals develop non-lymphoid neoplasia significantly later proliferation primary lymphocytes directly stalled suv39h1-dependent h3k9me-related senescent growth arrest response oncogenic ras thereby cancelling lymphomagenesis initial step suv39h1-deficient lymphoma cells grow rapidly unlike p53-deficient cells remain highly susceptible adriamycin-induced apoptosis contrast control suv39h1-deficient p53-deficient lymphomas senesce drug therapy apoptosis blocked results identify h3k9me-mediated senescence novel suv39h1-dependent tumour suppressor mechanism whose inactivation permits formation aggressive apoptosis-competent lymphomas response oncogenic ras
